$14.73
Currently 26 wall-street analysts regularly analyze the financials of Acadia Pharmaceuticals Inc. on a frequent basis to provide recommendations along with target share price. 26 analysts offering 12-month price forecasts for Acadia Pharmaceuticals Inc. (ACAD) have a share price target of $24.68. This median of share price forecast represents a 67.58% upside from the latest price of $14.73 as on 27.04.25.
As per the chart shown above, analysts believe that the Acadia Pharmaceuticals Inc. (ACAD) share price will touch around $24.68 in next 12-months.
Below is a chart showing the percentage difference between Acadia Pharmaceuticals Inc.'s share price and its median forecast price. As on 27.04.25, the difference is -33.88%
Based on 26 analysts tracking and researching Acadia Pharmaceuticals Inc. (ACAD) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 14 | 13 | 13 |
Outperform | 6 | 6 | 6 |
Hold | 6 | 7 | 6 |
Underperform | 0 | 0 | 0 |
Sell | 1 | 1 | 1 |